FDA to Use Strand Life Sciences' Genomics Reviewer Desktop Software for VXDS Program

Strand's software "will be advantageous to both the FDA and the industry to manage pharmacogenomic data submissions," FDA's Frederico Goodsaid said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.